The bylaw change makes passage of the 2026 Plan more likely given it had 56.4% support at the July meeting under a stricter standard. The 2025 Plan is unlikely to pass (only 32% support). Watch for YZiLabs voting stance given its 19.99% stake and prior activist filing; their support or opposition will determine outcomes. If the 2026 Plan fails, the company must resubmit it at the next meeting and the CEO Award cannot be granted.
Price Chart
Executive Summary
BNB Standard Corp is holding a special meeting to seek stockholder approval for two equity incentive plans. The 2025 Plan (525,000 shares) would vest RSUs for former executives and directors who no longer serve the company; the current Board makes no recommendation on it. The 2026 Plan (3,801,989 shares, ~7.8% of outstanding) is needed to provide equity compensation capacity, including a CEO award of 1,219,328 units ($6.95M value) to newly appointed CEO Alex Odagiu. The 2026 Plan failed at the July meeting due to broker non-votes counting as 'against' under the old bylaw standard; the company amended its bylaws to change the voting standard so abstentions and broker non-votes no longer count as votes against. The activist holder YZiLabs (19.99% stake) filed an SC 13D/A in June 2026, adding proxy fight context.
Key Facts
- Special meeting on December 4, 2026 to vote on two equity incentive plans
- 2025 Plan: 525,000 shares reserved, 92.5% of RSUs granted to persons no longer serving the company; current Board makes no recommendation
- 2026 Plan: 3,801,989 shares reserved (~7.8% of outstanding), increased from 2,400,000 after the July meeting
- CEO Award to Alex Odagiu: 1,219,328 units (487,731 RSUs + 731,597 PSUs) valued at $6,950,170 at $5.70/share
- 2026 Plan failed at July 2026 meeting with 56.4% support under old voting standard where broker non-votes counted as 'against'
- Bylaws amended October 2, 2026 to change voting standard: votes cast in favor must exceed votes cast opposing; abstentions and broker non-votes have no effect
- Quorum reduced from majority to one-third of outstanding shares
- YZiLabs Management Ltd. holds 19.99% stake; filed SC 13D/A on June 24, 2026
- Only 10,327 shares remain available under existing equity plans as of October 8, 2026
- Net income for fiscal year 2026 was $115.2 million; TSR declined from $123.73 (2024) to $47.39 (2026) on a $100 investment
Financial Impact
If both plans approved, total potential dilution of up to 4,326,988 shares (2025 Plan 524,999 + 2026 Plan 3,801,989) or ~8.9% of outstanding shares; CEO Award alone represents 2.5% of outstanding shares valued at $6.95M
Risk Factors
- 2025 Plan has no Board recommendation and only 32% prior support; likely to fail again
- 2026 Plan share reserve increased 58% from original proposal (2.4M to 3.8M shares), which may concern some shareholders
- Activist holder YZiLabs (19.99%) could vote against either plan, potentially blocking approval
- Quorum risk: only one-third of shares needed; if YZiLabs does not participate, quorum may be difficult to achieve without broker votes (no routine matters on ballot)
- CEO Award represents 2.5% dilution for a single executive; may face opposition from governance-focused shareholders
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001482541-26-000067 |
| Document: 0001482541-26-000067-index-headers.html | 0001482541-26-000067 |
| Document: 0001482541-26-000067-index.html | 0001482541-26-000067 |
| Document: 0001482541-26-000067.txt | 0001482541-26-000067 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | SC 13G/A | $4.95 | awaiting T+20 | awaiting T+20 | $4.95 (+0.00%) |
Oct 28, 2026 4d ago | DEF 14A | $5.41 | awaiting T+20 | awaiting T+20 | $4.95 (−8.50%) |
Oct 22, 2026 10d ago | 3 | $5.19 | awaiting T+20 | awaiting T+20 | $4.95 (−4.62%) |
Oct 19, 2026 13d ago | 8-K | $4.67 | awaiting T+20 | awaiting T+20 | $4.95 (+6.00%) |
Oct 7, 2026 25d ago | 3/A | $5.10 | awaiting T+20 | awaiting T+20 | $4.95 (+2.94%) |
Sep 11, 2026 7w ago | 8-K | $5.27 $5.20 | ▲ +1.33% | ▲ +3.59% | $4.95 (+6.07%) |
Aug 10, 2026 11w ago | 8-K | $2.43 $4.43 | ▲ +82.30% | ▲ +83.36% | $4.95 (+103.70%) |
Jul 10, 2026 16w ago | 3 | $2.81 $2.41 | ▼ −14.23% | ▼ −17.42% | $4.95 (+76.16%) |
Jun 23, 2026 18w ago | 8-K | $2.69 $2.95 | ▼ −9.67% | ▼ −7.73% | $4.95 (−84.01%) |
Jun 23, 2026 18w ago | 10-Q/A | $2.69 $2.95 | ▼ −9.67% | ▼ −7.73% | $4.95 (−84.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers